Overview of Uralyt Urato
| Property | Description |
|---|---|
| Active ingredient | Citric Acid, Potassium Citrate |
| Form | Granules for oral solution |
| Pharmacological class | Urinary Alkalinizer |
| General purpose | Enhances uric acid solubilization |
| Origin | Synthetic/Chemical Combination |
Uralyt Urato is a pharmaceutical agent specifically categorized as a urinary alkalinizer and an electrolyte preparation designed to regulate urinary acidity. It is a combination product, distinguishing it from single-substance treatments by merging two active chemical entities to achieve its effect. The medicine belongs to the group of agents used in the management of highly acidic urine, a state often associated with certain forms of kidney stones. This means the core function is to adjust the chemical balance within the urinary tract.
The formulation's action is targeted at modifying urinary pH. The inclusion of Potassium Citrate in this formulation not only provides the metabolic precursor for alkalinization but simultaneously supplies the essential electrolyte potassium, a key difference when compared to less metabolically diverse sodium-based alternatives. This supply of potassium is important for maintaining overall electrolyte balance.
Composition and Physical Form of Uralyt Urato Granules
The active ingredients in Uralyt Urato are Citric Acid and Potassium Citrate, which are chemical citrate salts. The medication is typically supplied by manufacturers in the form of granules for oral solution, meaning the patient dissolves the measured dose in water prior to ingestion. This granular presentation, dissolved to form an aqueous solution, ensures the active substances are readily available for absorption through oral administration. The citrate salts are then metabolized in the body, generating the alkaline compounds necessary to increase the urine's pH. This dosage form is often preferred in clinical practice for its precise titratability and ease of integrating into high-fluid intake regimens.
General Purpose: Alkalinization and Uric Acid Solubilization
The general purpose of Uralyt Urato is to promote the solubilization of uric acid by enhancing urinary pH regulation. By converting highly acidic urine into a less acidic, more alkaline state, the medication prevents uric acid from solidifying into crystalline structures. This fundamental action supports the body’s ability to manage high levels of acid in the urine, offering a typical neutral use scenario for individuals managing an excessively acidic urinary environment.
